FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jan. 30, 2015-- MEDNAX, Inc. (NYSE: MD), today announced the acquisition of MEMAC Associates, P.C., a private physician group practice based in Warren, Mich., and its related entity, Synergy Anesthesia, PLLC. At closing, 10 anesthesiologists, as well as 18 part-time anesthetists, became part of MEDNAX’s American Anesthesiology division, and will serve as one integrated practice.

MEMAC Associates was founded and incorporated in 1970. The practice provides services across a wide spectrum of subspecialty areas at St. John Macomb-Oakland Hospital, St. John Medical Center-Macomb Township ambulatory surgery center, and two Eastside Endoscopy Center locations. Synergy Anesthesia, a related entity, was established in 2013 to provide services at Synergy Spine & Orthopedic Surgery Center. The practice’s anesthesia services include general anesthesia, cardiac, neurosurgery (including spine), obstetric and acute pain management.

“MEDNAX shares the same long-term strategy and goals as our practice, which includes emphasis on research, education and quality initiatives that benefit our patients through better outcomes and improved patient satisfaction,” said Steven Rotter, M.D., who will serve as medical director for the practice. “As we all become impacted by healthcare reform, access to MEDNAX’s vast resources and back-office infrastructure will ensure that our mutual goals are met and that we can focus on providing exceptional care to our patients.”

MEDNAX’s American Anesthesiology division consists of more than 2,350 anesthesia providers, including more than 950 physicians and 1,400 anesthetists practicing in 13 states.

This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.

ABOUT MEDNAX

MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of neonatal, anesthesia, maternal-fetal and pediatric physician subspecialty services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a division of MEDNAX, was founded in 1979 and includes neonatal physicians who provide services at more than 360 neonatal intensive care units, and collaborate with affiliated maternal-fetal medicine, pediatric cardiology, pediatric critical care and other physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. American Anesthesiology, a division of MEDNAX, was established in 2007 and includes more than 2,350 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 2,625 physicians in 34 states and Puerto Rico. Additional information is available at www.mednax.com.

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

MEDNAX, Inc.
Charles Lynch, 954-384-0175, x 5692
Vice President, Strategy and Investor Relations
charles_lynch@mednax.com